INmune Bio Inc. - Common stock (NQ:INMB)
1.455
+0.005
(+0.34%)
Streaming Delayed Price
Updated: 1:56 PM EDT, Apr 20, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 110,827 |
| Open | 1.440 |
| Bid (Size) | 1.450 (1,000) |
| Ask (Size) | 1.460 (1,000) |
| Prev. Close | 1.450 |
| Today's Range | 1.410 - 1.460 |
| 52wk Range | 1.090 - 11.64 |
| Shares Outstanding | 17,703,692 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Earnings Scheduled For October 30, 2025 ↗
October 30, 2025
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
INmune Bio (INMB) Q2 Loss Widens 110% ↗
August 07, 2025
What's going on in today's pre-market session ↗
August 04, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
August 04, 2025
Frequently Asked Questions
Is INmune Bio Inc. - Common stock publicly traded?
Yes, INmune Bio Inc. - Common stock is publicly traded.
What exchange does INmune Bio Inc. - Common stock trade on?
INmune Bio Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for INmune Bio Inc. - Common stock?
The ticker symbol for INmune Bio Inc. - Common stock is INMB on the Nasdaq Stock Market
What is the current price of INmune Bio Inc. - Common stock?
The current price of INmune Bio Inc. - Common stock is 1.455
When was INmune Bio Inc. - Common stock last traded?
The last trade of INmune Bio Inc. - Common stock was at 04/20/26 01:56 PM ET
What is the market capitalization of INmune Bio Inc. - Common stock?
The market capitalization of INmune Bio Inc. - Common stock is 25.76M
How many shares of INmune Bio Inc. - Common stock are outstanding?
INmune Bio Inc. - Common stock has 26M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
